Clinical effect of alprostadil in patients with septic shock associated with acute respiratory distress syndrome

Medical Journal of Chinese People's Liberation Army

Volumn 42, Issue 9, 2017, Pages 805-809

  Liu, Li Ping ^a   Hu, Sheng Wen ^b   Shuai, Tian Kui ^a   Deng, Yuan Yuan ^a   Wang, Lin Jun ^a   Li, Yu Min ^a  

^a LANZHOU UNIVERSITY   (China)

^b General Hospital of Jingyuan Coal Industry Co Ltd   (China)

Author keywords

Adult; Alprostadil; Respiratory distress syndrome; Septic; Shock

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN; PROSTAGLANDIN E1;

ADULT; AIRWAY RESISTANCE; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; CARBON DIOXIDE TENSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE; LUNG COMPLIANCE; MALE; MORTALITY RATE; OXYGEN CONCENTRATION; OXYGEN TENSION; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; SEPTIC SHOCK;

EID: 85032786638     PISSN: 05777402     EISSN: None     Source Type: Journal    
DOI: 10.11855/j.issn.0577-7402.2017.09.10     Document Type: Article

References (20)

1. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: Results of the SOAP study[J]. Crit Care Med, 2006, 34(2): 344-353.
2. Blanco J, Muriel-Bombín A, Sagredo V, et al. Incidence, organ dysfunction and mortality in severe sepsis: A Spanish multicenter study[J]. Crit Care, 2008, 12: R1581.
3. Liu LP, Li B, Zhu L, et al. Clinical efficacy of nitroglycerin in patients with septic shock with ARDS[J]. Med J Chin PLA, 2015, 40(8): 647-651.
4. Wang CT, Dong CM, Bai ZG. Effectiveness of conventional treatment combined with continuous veno-venous hemofiltrationon treatment of acute respiratory distress syndrome: a Meta-analysis[J]. J Lanzhou Univ (Med Sci), 2015, V41(3): 67-74.
5. Zhao XD, Liu HS. Diagnosis and treatment strategy for acute respiratory distress syndrome in trauma patients-the rules and the timely and integrated treatment[J]. Med J Chin PLA, 2016, 41(8): 613-617.
6. Koyama A, Fujita T, Gejyo F, et al. Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease:a randomized, double-blind, placebo-controlled, phase II dose finding trial[J]. BMC Nephrol, 2015, 16(16): 165-180.
7. Goldstein SW, Gonzalez JR, Gagnon C, et al. Peripheral female genital arousal as assessed by thermography following topical genital application of alprostadil vs placebo arousal gel: a proofof-principle study without visual sexual stimulation[J]. Sex Med, 2016, 4(3): e166-e175.
8. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med, 2003, 31 (4): 1250-1256.
9. Bernard GR, Artigas A, Brigharn KL, et al. The American-European Consensus Conference of ARDS: def inition, mec ha n i sms, relevant outcomes and clinical trial coordination[J]. Am J Respir Crit Care Med, 1994, 149: 814-818.
10. Sun B, Li HJ, Liang HY. 87 report on the treatment of acute cerebral infarction with Lipo prostaglandin E1[J]. Med Herald, 2010, 29(11): 1454-1456.
11. Meng H. Clinical observation of alprostadil in the treatment of unstable angina pectoris[J]. Chin Modern Doctor, 2009, 47(24): 121-122.
12. Teng J, Li LQ. Clinical observation of Alprostadil Injection in the treatment of chronic renal failure[J]. Contemp Med, 2010, 16(18): 139-140.
13. Bha r athan VK, Chandr an B, Gopalakrishnan U, et al. Perioperative prostaglandin E1 infusion in living donor liver transplantation: A double-blind, placebo-controlled randomized trial[J]. Liver Transpl, 2016, 22(8): 1067-1074.
14. Ye Z, Lu H, Guo W, et al. The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and metaanalysis[J]. Med (Baltimore), 2016, 95(46): e5306.
15. Yue ZY, Song CY, Li WZ, et al. Effect on oxygen and shunt of acute lung injury in pigs with inhalation of prostaglandin E[J]. Chin J Anesthesiol, 2006, 26(5): 435-438.
16. Chen LX, Liu DZ. Protective effect of alprostadil on lung injury induced by mechanical ventilation in perioperative period[J]. Pract Med J, 2011, 27(13): 2432-2434.
17. Shi XY, Shen HY, Hong Y. Evaluation of the therapeutic effect of lipo prostaglandin E1 in post-traumatic acute respiratory distress syndrome[J]. Chin J Trauma, 2002, 18(10): 589-591.
18. Lao YG, Huang Q, Song XJ. Effects of alprostadil in pulmonary artery pressure and right ventricular function in patients with severe pulmonary contusion complicated with acute respiratory distress syndrome[J] Guangdong Med J, 2012, 33(4): 532-534.
19. Gao M, Xiao ZL, Li FX. Anti-infectious treatment in acute respiratory distress syndrome[J]. Med J Chin PLA, 2013, 38(2): 166-171.
20. Qiu HB, Dai JH, Yang Y, et al. Clinical epidemiology of acute respiratory distress syndrome from 1991 to 2001[J]. Chin Crit Care Med, 2003, 7(23): 489-491.